Get the Stockscreener App
21.70
2.06%
0.4369
Puretech Health Plc Adr stock is traded at $21.70, with a volume of 2,048.
It is up +2.06% in the last 24 hours and up +8.80% over the past month.
PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Wholly-Owned Programs, Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.
See More
Previous Close:
$21.26
Open:
$21.45
24h Volume:
2,048
Relative Volume:
0.36
Market Cap:
$519.42M
Revenue:
$1.70M
Net Income/Loss:
$-47.01M
P/E Ratio:
-12.76
EPS:
-1.7
Net Cash Flow:
$-157.28M
1W Performance:
-0.32%
1M Performance:
+8.80%
6M Performance:
-24.36%
1Y Performance:
-8.50%
1-Day Range:
$21.45
$21.70
1-Week Range:
$20.61
$22.82
52-Week Range:
$17.08
$34.00
Puretech Health Plc Adr Stock (PRTC) Company Profile
Name
Puretech Health Plc Adr
Sector
Industry
Phone
-
Address
-
Compare PRTC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| PRTC | 21.70 | 519.42M | 1.70M | -47.01M | -157.28M | -1.70 |
| VRTX | 451.23 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 743.35 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 591.82 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 248.79 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 102.14 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Puretech Health Plc Adr Stock (PRTC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-09-24 | Resumed | Leerink Partners | Outperform |
Puretech Health Plc Adr Stock (PRTC) Latest News
Rubrik Reports Q2 Results, Joins Ionis Pharmaceuticals, Hewlett Packard Enterprise And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
PureTech Health (LON:PRTC) Share Price Crosses Below 50-Day Moving Average of $175.96 - Defense World
PureTech Health: Results of the Tender Offer - StockTitan
PureTech Founded Entity Seaport Therapeutics Appoints Seasoned Executives to Management Team - Business Wire
PureTech Health: Launch of Proposed $100 Million Tender Offer at 250 Pence Per Ordinary Share - Yahoo Finance
Wall Street Analysts Predict an 82% Upside in PureTech Health PLC Sponsored ADR (PRTC): Here's What You ... - Yahoo News UK
PureTech Health (PRTC) is on the Move, Here's Why the Trend Could be Sustainable - Yahoo Finance
Down -8.13% in 4 Weeks, Here's Why PureTech Health PLC Sponsored ADR (PRTC) Looks Ripe for a Turnaround - Zacks Investment Research
The definitive Boston biotech layoff tracker for 2023 - The Business Journals
Wall Street Analysts Predict an 82% Upside in PureTech Health PLC Sponsored ADR (PRTC): Here's What You Should Know - Yahoo Finance
PureTech Announces Annual Results for Year Ended December 31, 2020 - Samoa Observer
The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine St - Benzinga
PureTech Health (PRTC) Stock Price, News & Analysis - MarketBeat
Puretech Health Plc Adr Stock (PRTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.69%
6.90%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):